Microbiome Supplement for Mild-to-Moderate Ulcerative Colitis
Part of Digestive system clinical trials.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18–75 years old
- You have been diagnosed with ulcerative colitis at least 3 months ago
- Your ulcerative colitis is currently mild to moderate (not severe)
- You have evidence of active inflammation in your colon based on blood/stool tests
- You are either not taking UC medications, or you have been on a stable dose of mesalamine (5-ASA) for at least 8 weeks
- You have not taken antibiotics, probiotics, or other microbiome products within the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
This trial tests a live bacteria powder (SK08) taken by mouth for ulcerative colitis. It aims to see if the bacteria can reduce inflammation and improve symptoms. You may qualify if standard treatments haven't worked well for you.
This study tests whether a modified Mediterranean diet can help people with mild to moderate ulcerative colitis. It may reduce inflammation and improve symptoms.
Hear when a new Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.